224 related articles for article (PubMed ID: 32179527)
1. An Engineered Double Lipid II Binding Motifs-Containing Lantibiotic Displays Potent and Selective Antimicrobial Activity against Enterococcus faecium.
Zhao X; Yin Z; Breukink E; Moll GN; Kuipers OP
Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32179527
[TBL] [Abstract][Full Text] [Related]
2. Interaction of type A lantibiotics with undecaprenol-bound cell envelope precursors.
Müller A; Ulm H; Reder-Christ K; Sahl HG; Schneider T
Microb Drug Resist; 2012 Jun; 18(3):261-70. PubMed ID: 22432708
[TBL] [Abstract][Full Text] [Related]
3. Lipid II-based antimicrobial activity of the lantibiotic plantaricin C.
Wiedemann I; Böttiger T; Bonelli RR; Schneider T; Sahl HG; Martínez B
Appl Environ Microbiol; 2006 Apr; 72(4):2809-14. PubMed ID: 16597986
[TBL] [Abstract][Full Text] [Related]
4. Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.
Bonelli RR; Schneider T; Sahl HG; Wiedemann I
Antimicrob Agents Chemother; 2006 Apr; 50(4):1449-57. PubMed ID: 16569864
[TBL] [Abstract][Full Text] [Related]
5. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
Li Q; Montalban-Lopez M; Kuipers OP
Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
[TBL] [Abstract][Full Text] [Related]
6. Molecular Recognition of Lipid II by Lantibiotics: Synthesis and Conformational Studies of Analogues of Nisin and Mutacin Rings A and B.
Dickman R; Mitchell SA; Figueiredo AM; Hansen DF; Tabor AB
J Org Chem; 2019 Sep; 84(18):11493-11512. PubMed ID: 31464129
[TBL] [Abstract][Full Text] [Related]
7. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity.
Wiedemann I; Breukink E; van Kraaij C; Kuipers OP; Bierbaum G; de Kruijff B; Sahl HG
J Biol Chem; 2001 Jan; 276(3):1772-9. PubMed ID: 11038353
[TBL] [Abstract][Full Text] [Related]
8. An alternative bactericidal mechanism of action for lantibiotic peptides that target lipid II.
Hasper HE; Kramer NE; Smith JL; Hillman JD; Zachariah C; Kuipers OP; de Kruijff B; Breukink E
Science; 2006 Sep; 313(5793):1636-7. PubMed ID: 16973881
[TBL] [Abstract][Full Text] [Related]
9. Role of lipid II and membrane thickness in the mechanism of action of the lantibiotic bovicin HC5.
Paiva AD; Breukink E; Mantovani HC
Antimicrob Agents Chemother; 2011 Nov; 55(11):5284-93. PubMed ID: 21876041
[TBL] [Abstract][Full Text] [Related]
10. A lesson in efficient killing from two-component lantibiotics.
Breukink E
Mol Microbiol; 2006 Jul; 61(2):271-3. PubMed ID: 16771845
[TBL] [Abstract][Full Text] [Related]
11. Lipid II-mediated pore formation by the peptide antibiotic nisin: a black lipid membrane study.
Wiedemann I; Benz R; Sahl HG
J Bacteriol; 2004 May; 186(10):3259-61. PubMed ID: 15126490
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of inhibition of Bacillus anthracis spore outgrowth by the lantibiotic nisin.
Gut IM; Blanke SR; van der Donk WA
ACS Chem Biol; 2011 Jul; 6(7):744-52. PubMed ID: 21517116
[TBL] [Abstract][Full Text] [Related]
13. In vivo cluster formation of nisin and lipid II is correlated with membrane depolarization.
Tol MB; Morales Angeles D; Scheffers DJ
Antimicrob Agents Chemother; 2015; 59(6):3683-6. PubMed ID: 25870072
[TBL] [Abstract][Full Text] [Related]
14. Insights into the mode of action of the two-peptide lantibiotic haloduracin.
Oman TJ; van der Donk WA
ACS Chem Biol; 2009 Oct; 4(10):865-74. PubMed ID: 19678697
[TBL] [Abstract][Full Text] [Related]
15. Lipid II as a target for antibiotics.
Breukink E; de Kruijff B
Nat Rev Drug Discov; 2006 Apr; 5(4):321-32. PubMed ID: 16531990
[TBL] [Abstract][Full Text] [Related]
16. Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
Escano J; Ravichandran A; Salamat B; Smith L
Appl Environ Microbiol; 2017 Jul; 83(14):. PubMed ID: 28500042
[TBL] [Abstract][Full Text] [Related]
17. Semisynthetic Lipopeptides Derived from Nisin Display Antibacterial Activity and Lipid II Binding on Par with That of the Parent Compound.
Koopmans T; Wood TM; 't Hart P; Kleijn LH; Hendrickx AP; Willems RJ; Breukink E; Martin NI
J Am Chem Soc; 2015 Jul; 137(29):9382-9. PubMed ID: 26122963
[TBL] [Abstract][Full Text] [Related]
18. New Insights into Nisin's Antibacterial Mechanism Revealed by Binding Studies with Synthetic Lipid II Analogues.
't Hart P; Oppedijk SF; Breukink E; Martin NI
Biochemistry; 2016 Jan; 55(1):232-7. PubMed ID: 26653142
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial mechanism of lantibiotics.
Islam MR; Nagao J; Zendo T; Sonomoto K
Biochem Soc Trans; 2012 Dec; 40(6):1528-33. PubMed ID: 23176511
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of the antimicrobial mechanism of mutacin 1140.
Smith L; Hasper H; Breukink E; Novak J; Cerkasov J; Hillman JD; Wilson-Stanford S; Orugunty RS
Biochemistry; 2008 Mar; 47(10):3308-14. PubMed ID: 18266322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
